Inhibition of TGFβ signaling in cancer therapy

Research output: Contribution to journalReview articlepeer-review

39 Scopus citations


Recent evidence continues to support a central role for TGFβ in tumor maintenance and progression. Although this may involve TGFβ-mediated paracrine effects that modulate the tumor microenvironment and the host immune system, some studies causally implicate autocrine TGFβ in cancer cell motility and survival. Other recent evidence indicates synergy between oncogene and TGFβ signaling in epithelial cell transformation. This suggests opportunities for dissecting molecular mechanisms of cross-talk as well as providing insights into possible combinatorial molecular anticancer therapies that will include TGFβ inhibitors.

Original languageEnglish (US)
Pages (from-to)30-37
Number of pages8
JournalCurrent Opinion in Genetics and Development
Issue number1
StatePublished - Feb 2006

ASJC Scopus subject areas

  • Genetics
  • Developmental Biology


Dive into the research topics of 'Inhibition of TGFβ signaling in cancer therapy'. Together they form a unique fingerprint.

Cite this